Bufotenine Explained: Sources, Effects, and Safety

Bufotenine is one of the most misunderstood molecules in the psychedelic conversation. It shares a name with a family of toads, a chemical backbone with serotonin, and a legal category with substances it barely resembles in effect. People searching for it are usually trying to answer one of two questions: is bufotenine what makes "toad medicine" work, and is it safe?

The short answers are no, and not in the way most people assume. Both answers matter for anyone considering a physician-supervised 5-MeO-DMT program.

This article is a companion to our closer comparison of bufotenine and DMT. Here the focus is the compound itself: where it comes from, what it does in the body, why it is so often confused with 5-MeO-DMT, and why that confusion is worth clearing up before you sit down with a medical team.

What Is Bufotenine, Chemically?

Bufotenine's full chemical name is 5-hydroxy-N,N-dimethyltryptamine, usually shortened to 5-HO-DMT. Strip that down and it is serotonin with two methyl groups added to the nitrogen at the end of its side chain. Serotonin itself is 5-hydroxytryptamine, which is why bufotenine is sometimes described as dimethylated serotonin.

That single hydroxyl group at the 5-position explains most of why bufotenine behaves so differently from its close relatives. DMT has nothing at that position, and 5-MeO-DMT carries a methoxy group there instead.

The hydroxyl makes bufotenine considerably more polar, which means it is less able to cross fatty membranes, including the blood-brain barrier. A molecule that struggles to reach the brain in meaningful concentrations will spend more of its effect on the body.

The compound was first isolated from toad skin secretions in the early twentieth century and takes its name from the toad genus Bufo. Chemists worked out its structure and synthesized it in the 1930s, decades before anyone discussed it in the context of psychedelic therapy.

Where Does Bufotenine Come From?

Bufotenine turns up in a surprising range of places, which is part of why its reputation is so tangled.

Toads. Many toad species produce bufotenine in the parotoid glands behind their eyes, alongside a mix of other defensive chemicals. The cane toad, now established across Florida, Australia, and much of the tropics, is a bufotenine producer. So is the Sonoran Desert toad, though in that species bufotenine is a minor component next to a far more famous one, which we will come to shortly.

Seeds. In South America, the seeds of Anadenanthera peregrina and Anadenanthera colubrina have been prepared as ceremonial snuffs, known regionally as yopo, cebil, or vilca, for a very long time. Bufotenine is the principal alkaloid in those seeds. This is the one traditional context in which bufotenine itself, rather than a relative, is the intended active compound.

The human body. Bufotenine has been detected in trace amounts in human urine. It appears to be one of several tryptamines the body produces in tiny quantities as a byproduct of normal serotonin chemistry. Its role, if any, in ordinary physiology is not well understood.

Fungi. Small amounts have been reported in a handful of mushroom species, though never at levels that made those species relevant to human use.

Is Bufotenine the Same as the Toad's Active Compound?

No, and this is the confusion that sends the most people down the wrong path. The Sonoran Desert toad, Incilius alvarius, is the species behind what is commonly called bufo, toad medicine, or toad venom. Its secretion is unusual among toads because it is dominated not by bufotenine but by 5-methoxy-N,N-dimethyltryptamine, or 5-MeO-DMT. The Italian pharmacologist Vittorio Erspamer and his colleagues characterized this in the 1960s, identifying 5-MeO-DMT as a major constituent of the dried secretion.

So when people describe the intense, brief, and often ego-dissolving experience associated with the toad, they are describing 5-MeO-DMT. Bufotenine is present in the same secretion in far smaller amounts and is not what produces that experience. The two compounds differ by a single carbon atom, a methyl group on the oxygen, and yet that difference changes how easily the molecule reaches the brain, how it engages serotonin receptors, and what a person actually feels.

The naming makes things worse. When 5-MeO-DMT entered formal clinical development, it received the international nonproprietary name mebufotenin. That word looks like bufotenine with a prefix, and it is easy to assume the two are interchangeable.

They are not. Mebufotenin is 5-MeO-DMT, the compound now being studied in controlled trials for treatment-resistant depression, while bufotenine is a different molecule with a different profile. If a clinic or a website uses the terms loosely, that is a signal to ask more careful questions.

What Does Bufotenine Do in the Body?

In laboratory studies bufotenine binds strongly to serotonin receptors, including the 5-HT2A receptor that is central to the effects of classic psychedelics. On paper, that would predict a psychedelic. In practice, the picture is muddier, largely because of that polar hydroxyl group.

Mid-century human experiments, conducted under ethical standards that would not be acceptable today, gave bufotenine intravenously and reported effects that were mostly physical: facial flushing that could shade toward purple, chest tightness, changes in heart rate and blood pressure, and visual disturbances that subjects generally found unpleasant rather than meaningful. A 1956 report in the journal Science by Fabing and Hawkins is the best-known example. Later researchers questioned whether bufotenine was meaningfully psychoactive at all.

That view was challenged in 2001, when the ethnobotanist Jonathan Ott published a series of careful self-experiments in the Journal of Psychoactive Drugs. Ott reported that when bufotenine free base was vaporized or taken intranasally, it produced clear psychoactive effects while the peripheral side effects were milder than the older injection studies suggested. The route of administration, in other words, changes what bufotenine does.

Taken together, the evidence describes a peripherally active serotonin agonist with psychoactive potential that depends heavily on dose and route, and with a cardiovascular signature most people would not choose to experience. That is a very different profile from 5-MeO-DMT, which reaches the brain readily and, when inhaled, acts within seconds.

Is Bufotenine Dangerous?

On its own, bufotenine's main concerns are cardiovascular. It can raise blood pressure and constrict blood vessels, and it has been associated with intense flushing and chest discomfort. For someone with an undiagnosed heart condition, that is not trivial.

The larger danger comes from where bufotenine is usually found rather than from the molecule itself. Toad secretions are never pure bufotenine. Cane toad secretion in particular contains bufadienolides, steroid compounds that act on the heart much as digitalis does, and ingesting cane toad secretion or products made from it has caused serious poisonings and deaths.

In the mid-1990s the US Centers for Disease Control and Prevention documented fatalities in New York City linked to a topical product sold as an aphrodisiac that turned out to contain toad-derived bufadienolides. "Toad licking" stories tend to be treated as jokes; the toxicology is not funny.

Legally, bufotenine is a Schedule I controlled substance in the United States and has been since the Controlled Substances Act of 1970. 5-MeO-DMT was added to Schedule I separately in 2011. Neither has an accepted medical use in the United States at present, which is one reason legitimate supervised programs operate in jurisdictions such as Mexico under medical oversight rather than in US clinics.

Why Bufotenine Matters for Screening Before a 5-MeO-DMT Program

If bufotenine is not the compound a supervised program works with, why spend an article on it? Because understanding it makes you a better-informed participant in your own screening.

First, it clarifies what you are being offered. Programs may work with pharmaceutical-grade synthetic 5-MeO-DMT, with toad-derived material, or with both. Synthetic material is a single known compound at a known dose.

Toad-derived secretion is a natural mixture whose 5-MeO-DMT content varies from animal to animal and season to season, and it carries bufotenine and other constituents along with it. Neither choice is automatically right, but you should know which one is on the table and why.

Second, it sharpens the medication conversation. Bufotenine, 5-MeO-DMT, and DMT are all serotonergic. Any medical intake worth the name will ask about antidepressants, MAO inhibitors, lithium, and other drugs that interact with serotonin, and about heart conditions, blood pressure, and family cardiac history.

Physician review of that history is not a formality; it is the mechanism that keeps a powerful experience within safe boundaries. Our 5-MeO-DMT safety overview walks through what that screening typically covers.

Third, it protects you from the gray market. Products sold online as toad venom, dried secretion, or "bufo" may come from the wrong species entirely, may contain cardioactive toxins, and offer no dose control. Knowing that the cane toad and the Sonoran Desert toad are chemically different animals is exactly the kind of knowledge that prevents a bad decision.

A physician-supervised setting exists to remove these unknowns. The compound is identified, the dose is measured, the participant is screened, and a medical team is present throughout. None of that guarantees an outcome, and no responsible program will promise one. What it does is turn a molecule with a confusing reputation into a defined clinical variable.

If you are weighing a 5-MeO-DMT program and want to understand how screening, preparation, and medical supervision fit together, the team at MindScape Retreat offers physician-led consultations that begin with your medical history rather than a sales pitch. Questions about bufotenine, 5-MeO-DMT, and the difference between them are exactly what those conversations are built to answer.

This article is educational and is not medical advice. It does not diagnose, treat, or guarantee outcomes for any condition. Discuss any psychedelic program with a licensed physician who knows your full medical history. If you are in crisis in the United States, call or text 988.